Super V3 Investment Limited Partnership Jafco, 10% Owner at Tracon Pharmaceuticals, Inc. (TCON), sold 21,920 shares at $10.09 ($221K) on 2015-10-07, disclosed to the SEC on 2015-10-08.
Open-market sale of $221k TCON by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.09 | 12,288 | $124K | 56.0% |
| 2 | $10.11 | 9,632 | $97K | 44.0% |
| Total | $10.10 avg | 21,920 | $221K | 100% |
| Filing → |
| TCON | SELL | 2015-10-13 | $32K | — | Filing → |
| TCON | SELL | 2015-10-06 | $152K | — | Filing → |
| TCON | SELL | 2015-09-29 | $92K | — | Filing → |